D. Compère

发表

Stereocontrolled Alkylation of Chiral Pyridinium Salt Toward a Short Enantioselective Access to 2-Alkyl- and 2,6-Dialkyl-1,2,5,6-Tetrahydropyridines

B. Das, C. Marazano, L. Gil, 2000 .

Thiophene and bioisostere derivatives as new MMP12 inhibitors.

R. Wrigglesworth, S. Blais, A. Dublanchet, 2011, Bioorganic & medicinal chemistry letters.

Enantioselective Access to Lobelia Alkaloids

B. Das, C. Marazano, D. Compère, 1999 .

An Enantioselective Entry to Substituted 6-Membered Nitrogen Heterocycles from Chiral Pyridinium Salts via Selective Epoxidation of Tetrahydropyridine Intermediates

A. Chiaroni, C. Marazano, L. Gil, 2000 .

An Enantioselective Entry to Substituted 6-Membered Nitrogen Heterocycles from Chiral Pyridinium Salts via Selective Epoxidation of Tetrahydropyridine Intermediates.

A. Chiaroni, C. Marazano, L. Gil, 2001 .

Crystal structures of novel non-peptidic, non-zinc chelating inhibitors bound to MMP-12.

Sophie Perrier, S. Dufour, Renaud Morales, 2004, Journal of molecular biology.

Chameleon catches in combinatorial chemistry: Tebbe olefination of polymer supported esters and the synthesis of amines, cyclohexanones, enones, methyl ketones and thiazoles

A. Barrett, R. S. Roberts, A. Commerçon, 1998 .

QGC606, a best-in-class orally active centrally acting aminopeptidase A inhibitor prodrug, for treating heart failure following myocardial infarction.

O. Agbulut, C. Llorens-Cortes, M. Keck, 2022, The Canadian journal of cardiology.

NI956/QGC006, a Potent Orally Active, Brain-Penetrating Aminopeptidase A Inhibitor for Treating Hypertension

B. Roques, C. Llorens-Cortes, M. Keck, 2019, Hypertension.

Structure-based design and synthesis of novel non-zinc chelating MMP-12 inhibitors.

J. Hamon, P. Ducrot, P. Cluzeau, 2005, Bioorganic & medicinal chemistry letters.

Structure-based design and synthesis of novel non-zinc chelating MMP-12 inhibitors.

Pierre Ducrot, Jacques Hamon, Alexis Denis, 2005, Bioorganic & medicinal chemistry letters.